Method of treating neurodegenerative diseases

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/55 (2006.01) A61K 31/27 (2006.01) A61K 31/34 (2006.01) A61K 31/38 (2006.01) A61K 31/40 (2006.01) A61K 31/425 (2006.01)

Patent

CA 2339140

The present invention provides a method of treating a neurodegenerative disease, and in particular Alzheimer's disease, Mild Cognitive Impairment or other objective memory impairment which comprises the co-administration of ARICEPT or other cholinesterase inhibitor or cholenergic angonist and an effective amount of a selective COX-2 inhibitor. Although a wide range of COX- 2 inhibitors may be employed in combination with ARICEPT, there are preferred choices which are specifically set forth herein.

La présente invention concerne une méthode de traitement d'une maladie neurodégénérative, en particulier la maladie d'Alzheimer, de troubles cognitifs légers, ou d'autres troubles objectifs de la mémoire. Cette méthode consiste à coadministrer au patient concerné de l'ARICEPT, ou un autre inhibiteur cholinestérasique ou agoniste cholénergique, avec une dose efficace d'un inhibiteur de COX-2 sélectif. Bien qu'une grande variété d'inhibiteurs de COX-2 puisse être utilisée, nous présentons dans cette invention une sélection d'inhibiteurs préférés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method of treating neurodegenerative diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating neurodegenerative diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating neurodegenerative diseases will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1365179

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.